Nourianz (istradefylline), new add-on drug to treat off episodes in adults with Parkinson’s disease
7 Settembre 2019
The U.S. Food and Drug Administration has approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing
